Literature DB >> 16809399

Antibody arrays: technical considerations and clinical applications in cancer.

Marta Sanchez-Carbayo1.   

Abstract

Antibody arrays represent one of the high-throughput techniques that are able to detect multiple proteins simultaneously. One of the main advantages of this technology over other proteomic approaches is that the identities of the measured proteins are known or can be readily characterized, allowing a biological interpretation of the results. Features such as lower sample volume and antibody concentration requirements, higher format versatility, and reproducibility support the increasing use of antibody arrays in cancer research. Clinical applications include disease marker discovery for diagnosis, prognosis, and drug response, characterization of signaling and protein pathways, and modifications associated with disease development and progression. This report presents an overview of technical issues of the main antibody array formats and various applications in cancer research. Antibody arrays are high-throughput tools that improve the functional characterization of molecular bases for disease. Furthermore, identification and validation of protein expression patterns, characteristic of cancer progression, and tumor subtypes may intervene and improve tailored therapies in the clinical management of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809399     DOI: 10.1373/clinchem.2005.059592

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  36 in total

Review 1.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

2.  An entropic perspective of protein stability on surfaces.

Authors:  Thomas A Knotts; Nitin Rathore; Juan J de Pablo
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

3.  Microarray methods for protein biomarker detection.

Authors:  Hye Jin Lee; Alastair W Wark; Robert M Corn
Journal:  Analyst       Date:  2008-06-05       Impact factor: 4.616

Review 4.  Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens.

Authors:  Marta Sanchez-Carbayo
Journal:  Tumour Biol       Date:  2010-01-21

5.  Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases.

Authors:  Faina Linkov; Robert L Ferris; Zoya Yurkovetsky; Adele Marrangoni; Lyudmila Velikokhatnaya; William Gooding; Brian Nolan; Matthew Winans; Eric R Siegel; Anna Lokshin; Brendan C Stack
Journal:  Proteomics Clin Appl       Date:  2008-10-10       Impact factor: 3.494

Review 6.  Nanomedicine--challenge and perspectives.

Authors:  Kristina Riehemann; Stefan W Schneider; Thomas A Luger; Biana Godin; Mauro Ferrari; Harald Fuchs
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

7.  Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.

Authors:  Christoph Schröder; Anette Jacob; Sarah Tonack; Tomasz P Radon; Martin Sill; Manuela Zucknick; Sven Rüffer; Eithne Costello; John P Neoptolemos; Tatjana Crnogorac-Jurcevic; Andrea Bauer; Kurt Fellenberg; Jörg D Hoheisel
Journal:  Mol Cell Proteomics       Date:  2010-02-16       Impact factor: 5.911

8.  Oncoproteomic profiling with antibody microarrays.

Authors:  Mohamed Ss Alhamdani; Christoph Schröder; Jörg D Hoheisel
Journal:  Genome Med       Date:  2009-07-06       Impact factor: 11.117

9.  Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.

Authors:  René Stempfer; Parvez Syed; Klemens Vierlinger; Rudolf Pichler; Eckart Meese; Petra Leidinger; Nicole Ludwig; Albert Kriegner; Christa Nöhammer; Andreas Weinhäusel
Journal:  BMC Cancer       Date:  2010-11-16       Impact factor: 4.430

10.  Antibody profiling with protein antigen microarrays in early stage cancer.

Authors:  Brian C-S Liu; Daniel A Dijohnson; Dennis J O'Rourke
Journal:  Expert Opin Med Diagn       Date:  2012-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.